Dr. Ashutosh Sachdeva received his medical degree from University of Delhi. He completed his residency in Internal Medicine at Saint Louis University School of Medicine, in Saint Louis, Missouri. Upon completion of his fellowship in Pulmonary Diseases and Critical Care medicine at Saint Louis University School of Medicine he stayed on as faculty in the Division of Pulmonary, Critical Care, and Sleep Medicine for three years. He then spent a year at Virginia Commonwealth Health Sciences in Richmond, advancing his training in Interventional Pulmonology.

Dr. Ashutosh Sachdeva is Associate Professor of Medicine at the University of Maryland School of Medicine and Director of Interventional Pulmonology and Bronchoscopy Services at the University of Maryland Medical Center. He is board-certified in Pulmonary Disease, Critical Care Medicine, and Interventional Pulmonology and is nationally recognized for his expertise in advanced bronchoscopy, thoracic oncology, airway disease, and minimally invasive pulmonary interventions.

After earning his medical degree from Maulana Azad Medical College at the University of Delhi, Dr. Sachdeva completed residency training in Internal Medicine at Saint Louis University, followed by fellowship training in Pulmonary and Critical Care Medicine and advanced Interventional Pulmonology. He subsequently earned an Executive MBA from the Robert H. Smith School of Business at the University of Maryland, reflecting his commitment to healthcare leadership, innovation, and organizational growth.

Since joining the University of Maryland in 2012, Dr. Sachdeva has built one of the region’s most comprehensive Interventional Pulmonology programs. Under his leadership, the program has expanded across multiple hospitals within the University of Maryland Medical System, the Baltimore Veterans Affairs Medical Center, and the University of Maryland Greenebaum Comprehensive Cancer Center. He also founded and directs the University of Maryland Interventional Pulmonology Fellowship Program, which has trained specialists who now practice throughout the United States.

Dr. Sachdeva’s clinical practice focuses on the diagnosis and treatment of complex thoracic diseases using advanced minimally invasive techniques. His expertise includes robotic and image-guided bronchoscopy, endobronchial ultrasound, lung cancer diagnosis and staging, therapeutic bronchoscopy, pleural interventions, management of complex airway disorders, and Bronchoscopic therapies for chronic obstructive pulmonary disease (COPD). He is particularly interested in integrating advanced imaging, navigation technologies, and emerging therapeutic platforms to improve the early detection and treatment of lung cancer.

As a clinician-scientist, Dr. Sachdeva has served as principal investigator and co-investigator on numerous multicenter clinical trials evaluating innovative technologies and therapies in interventional pulmonology, thoracic oncology, chronic bronchitis, emphysema, airway disease, and pulmonary alveolar proteinosis. His research focuses on advancing minimally invasive technologies that enhance diagnostic precision, procedural safety, and patient outcomes.

Education and mentorship remain central to Dr. Sachdeva’s professional mission. Through his leadership of the University of Maryland Interventional Pulmonology Fellowship Program, he has helped train the next generation of pulmonary and interventional pulmonology specialists. He is a frequent invited speaker at national and international conferences and has contributed to the advancement of educational standards through leadership roles within the American Association for Bronchology and Interventional Pulmonology (AABIP), where he currently serves as Secretary-Treasurer and Vice-Chair of the Joint Interventional Pulmonology Fellowship Accreditation Committee.

At the heart of Dr. Sachdeva’s approach to medicine is a commitment to patient-centered, value-based care. He believes that time is the most valuable commodity patients entrust to their physicians. Every patient encounter represents an opportunity not only to diagnose and treat disease, but also to listen, educate, reassure, and build meaningful partnerships. He is committed to providing compassionate, empathetic care while ensuring that patients and families remain active participants in the decision-making process.

Dr. Sachdeva strongly believes that the best outcomes are achieved through multidisciplinary collaboration. By bringing together specialists across pulmonary medicine, thoracic surgery, medical oncology, radiation oncology, radiology, pathology, and supportive care services, he strives to develop comprehensive, individualized treatment plans tailored to each patient’s needs and goals.

Outside of medicine, Dr. Sachdeva is a devoted husband and father who values the time spent with his family above all else. His family serves as a constant source of inspiration, perspective, and balance. He is also passionate about travel and exploring different cultures around the world. Through these experiences, he seeks to develop greater cultural intelligence, broaden his understanding of diverse perspectives, and continuously grow both personally and professionally. He embraces the philosophy of lifelong learning and strives each day to become a better physician, educator, leader, and person.

Through clinical care, education, research, and leadership, Dr. Sachdeva remains dedicated to advancing the field of interventional pulmonology and improving the lives of patients with complex pulmonary and thoracic diseases.

Bronchoscopic lung volume reduction for symptomatic patients with severe Emphysema/COPD.

Thiboutot J, Kapp CM, Illei P, Shofer S, Gilbert CR, DiBardino D, DeMaio A, Sethi S, Wahidi MM, Benn BS, Gillespie C, Salmon C, Angel L, Sachdeva A, Holden VK, Paez R, Duke JD, Lentz RJ, Vachani A, Pastis N, Molena D, Tackett S, Jones MR, Rahman NM, Silvestri G, Maldonado F, Yarmus L; Interventional Pulmonary Outcomes Group. Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy: The FROSTBITE-2 Randomized Clinical Trial. JAMA. 2026 May 18:e267908. doi: 10.1001/jama.2026.7908. Epub ahead of print. PMID: 42149700; PMCID: PMC13184779.

Kalchiem-Dekel O, Kezlarian-Sachs BE, Ma X, Christos PJ, Auclair R, Chang JC, Lin O, Legesse TB, Falchi L, Drilon A, Rakočević R, Oberg CL, Lee RP, Chawla M, Sachdeva A, Pickering EM, Holden VK, Husta BC. The Complementary Roles of EBUS-Guided Needle Aspiration, Mini-Forceps, and Cryobiopsy in the Investigation of Mediastinal Lesions. Ann Am Thorac Soc. 2026 Feb 21:aaoag040. doi: 10.1093/annalsats/aaoag040. Epub ahead of print. PMID: 41721745.

Kalchiem-Dekel O, Sachdeva A. Gauge, geometry, or adhesion force-biopsy tools in a specific disease state for endobronchial ultrasound bronchoscopy. Ann Am Thorac Soc. 2026 Feb 1;23(2):176-178. doi: 10.1093/annalsats/aaoaf059. PMID: 41759069.

Trapnell BC, Inoue Y, Bonella F, Wang T, McCarthy C, Arai T, Akasaka K, Mariani F, Mogulkoc N, Song JW, Baba T, Jouneau S, Numakura T, Öcal N, Mihaltan F, Ataya A, Bendstrup E, Campo I, Carey B, Arena R, Robinson B, Fleming R, Wasfi Y, Pratt R; IMPALA-2 Trial Investigators. Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis. N Engl J Med. 2025 Aug 21;393(8):764-773. doi: 10.1056/NEJMoa2410542. PMID: 40834301.

Sachdeva A, Sethi S. Motivation and Learning: Leveraging Artificial Intelligence to Improve Bronchoscopy Performance. Chest. 2024 Feb;165(2):243-245. doi: 10.1016/j.chest.2023.09.018. PMID: 38336435.

Holden VK, Sachdeva A. Timely stenting in malignant central airway obstruction: Timely guidelines and time for multidisciplinary care. Respirology. 2024 Sep;29(9):745-746. doi: 10.1111/resp.14802. Epub 2024 Jul 25. PMID: 39053970.

Criner GJ, Mallea JM, Abu-Hijleh M, Sachdeva A, Kalhan R, Hergott CA, Lazarus DR, Mularski RA, Calero K, Reed MF, Nsiah-Dosu S, Himes D, Kubo H, Kinsey CM, Majid A, Hogarth DK, Kaplan PV, Case AH, Makani SS, Chen TM, Delage A, Zgoda M, Shepherd RW. Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE. Ann Am Thorac Soc. 2024 Feb;21(2):251-260. doi: 10.1513/AnnalsATS.202306-520OC. PMID: 37948704; PMCID: PMC10848907.

Lee P, Sachdeva A. Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future. Curr Opin Pulm Med. 2024 Jan 1;30(1):1-2. doi: 10.1097/MCP.0000000000001037. Epub 2023 Dec 7. PMID: 38051174.

Li J, Dhilipkannah P, Holden VK, Sachdeva A, Todd NW, Jiang F. Dysregulation of lncRNA MALAT1 Contributes to Lung Cancer in African Americans by Modulating the Tumor Immune Microenvironment. Cancers (Basel). 2024 May 15;16(10):1876. doi: 10.3390/cancers16101876. PMID: 38791954; PMCID: PMC11119359.

Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, Lazarus DR, Casal R, Benzaquen SB, Holladay RC, Wellikoff A, Calero K, Rumbak MJ, Branca PR, Abu-Hijleh M, Mallea JM, Kalhan R, Sachdeva A, Kinsey CM, Lamb CR, Reed MF, Abouzgheib WB, Kaplan PV, Marrujo GX, Johnstone DW, Gasparri MG, Meade AA, Hergott CA, Reddy C, Mularski RA, Case AH, Makani SS, Shepherd RW, Chen B, Holt GE, Martel S. Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2019 Dec 1;200(11):1354-1362. doi: 10.1164/rccm.201902-0383OC. PMID: 31365298; PMCID: PMC6884033.

Clinical study:

Principal investigator on EMPROVE clinical trial of IBV valves in severe Emphysema/COPD. The study aims to evaluate the impact of lung volume reduction using one way-valves in the airways of single lobe of the lung and is actively recruiting patients. Early detection of lung cancer and evaluation of innovative and evolving technologies for ablation of peripheral lung tumors. Minimally invasive procedures for diagnosis and staging of lung cancer. Management of tracheal and airway stenosis with minimally invasive procedures for rapid relief and long-term management. Expertise with use of ablative modalities including cryotherapy, argon plasma coagulation, LASER, and electrocautery.

Co-Investigator, truFreeze® Spray Cryotherapy Patient Registry, a joint registry with Division of Gastroenterology at University of Maryland Medical Center. The purpose is to learn about effective and safety of spray cryotherapy in patients with malignant and non-malignant airway disease.  Bronchial thermoplasty for patients with severe Asthma. Dr. Sachdeva collaborates with Dr. Kathryn Robinett, expert in Asthma, in the Division of Pulmonary and Critical Care for selecting patients who would benefit from the procedure.